Appili Therapeutics (APLIF) Cash from Financing (Quarterly): 0.1232M

Appili Therapeutics, Inc. (APLIF)

0.0068 0.00 (0.00%) USD | OTCM | Oct 26, 16:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Start Trial.

Date	Value
June 30, 2026	0.1232M
March 31, 2026	0.0701M
December 31, 2025	0.1172M
September 30, 2025	-0.022M
June 30, 2025	-0.0212M
March 31, 2025	-0.0368M
December 31, 2024	-0.0257M
September 30, 2024	-0.0195M
June 30, 2024	0.2611M
March 31, 2024	-0.0255M
December 31, 2023	-0.0206M
September 30, 2023	0.0971M
June 30, 2023	0.0944M
March 31, 2023	1.610M
December 31, 2022	-0.016M
September 30, 2022	-0.0162M
June 30, 2022	3.021M

Date	Value
March 31, 2022	0.8553M
December 31, 2021	4.197M
September 30, 2021	2.609M
June 30, 2021	-0.0036M
March 31, 2021	0.1238M
December 31, 2020	0.5032M
September 30, 2020	0.064M
June 30, 2020	11.92M
March 31, 2020	6.873M
December 31, 2019	-0.0134M
September 30, 2019	-0.049M
June 30, 2019	0.2033M
March 31, 2019	1.10M
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018	1.059M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks